Thursday, July 05, 2018 6:32:55 PM
From Sree Koneru
Thank you for your e-mail. We are in the process of seeking guidance from the FDA on the appropriate time to submit the RecoveryRx 510(k), with respect to the Innovation Challenge. The Allay study is going strong and we expect a timely completion this year, however we do not have additional information on when the 510(k) will be filed. Any updates that we have regarding these two matters will be made publicly available via a press release.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
